Cognition Therapeutics
Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.
Key facts
| CAGE Code | 5CQK3 |
|---|---|
| Legal Name | Cognition Therapeutics, Inc. |
| Company Operating Status | Active |
| Full Address | 2403 Sidney Street Pittsburgh, PA 15203 United States |
| Public/Private | Public |
| Stock Symbol | CGTX |
| Ticker Symbol | CGTX |
| Wellfound ID | cognition-therapeutics |
| Wikidata ID | Q30287217 |
Contact details
Email and phone for Cognition Therapeutics are available to signed-in members of CliffBio.
Sign in to view